Your Location:
Home >
Browse articles >
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
RESEARCH | Updated:2026-06-10
    • PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

    • Military Medical Research   Vol. 13, Issue 5, Pages: 747-765(2026)
    • DOI:10.1186/s40779-025-00679-z    

      CLC:
    • Received:26 January 2025

      Accepted:25 November 2025

      Online First:06 January 2026

      Published:2026-05

    Scan QR Code

  • Yu Wang, Yong-Bo Xiang, Xiao-Wei Chen, et al. PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer[J]. Military Medical Research, 2026, 13(5): 747-765. DOI: 10.1186/s40779-025-00679-z.

  •  
  •  

0

Views

34

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Enhancing the clinical relevance of haemorrhage prediction models in trauma
Artificial intelligence and machine learning for hemorrhagic trauma care
Cell-free DNA in sepsis: from molecular insights to clinical management
A methodological guideline for consciousness assessment via neural electrophysiological activity
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice

Related Author

Sankalp Tandle
Jared M. Wohlgemut
Max E. R. Marsden
Erhan Pisirir
Evangelia Kyrimi
Rebecca S. Stoner
William Marsh
Zane B. Perkins

Related Institution

Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London
The Royal London Hospital, Barts Health NHS Trust
Department of Electronic Engineering and Computer Science, Queen Mary University of London
Academic Department of Military Surgery and Trauma, Research and Clinical Innovation, The Royal Centre for Defence Medicine
Royal Canadian Medical Services
0